Can urinary excretion rate of 8-isoprostrane and malonaldehyde predict postoperative cognitive dysfunction in aging?

Neurological Sciences

Volumn 34, Issue 9, 2013, Pages 1665-1669

  Cheng, Qinghao ^a   Wang, Jiawan ^b   Wu, Anshi ^b   Zhang, Rujin ^c   Li, Lei ^a   Yue, Yun ^b  

^a CHINA MEITAN GENERAL HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Beijing United Family Hospital   (China)

Author keywords

8 Isoprostrane; Creatinine; Malonaldehyde; Oxidative stress; Postoperative cognitive dysfunction

Indexed keywords

8 ISOPROSTANE; CREATININE; MALONALDEHYDE;

AGED; AGING; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENERAL SURGERY; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ORTHOPEDIC SURGERY; OXIDATIVE STRESS; POSTOPERATIVE COMPLICATION; PREDICTION; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; URINARY EXCRETION;

AGED; AGING; BIOLOGICAL MARKERS; COGNITION DISORDERS; DINOPROST; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUMINESCENT MEASUREMENTS; MALE; MALONDIALDEHYDE; NEUROPSYCHOLOGICAL TESTS; ORTHOPEDIC PROCEDURES; OXIDATIVE STRESS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD;

EID: 84885425385     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-013-1314-z     Document Type: Article

References (28)

1. Bittner EA, Yue Y, Xie Z (2011) Brief review: anesthetic neurotoxicity in the elderly, cognitive dysfunction and Alzheimer's disease. Can J Anaesth 58(2):216-223
2. Phillips-Bute B, Mathew JP, Blumenthal JA, Grocott HP, Laskowitz DT, Jones RH, Mark DB, Newman MF (2006) Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med 68(3):369-375
3. Perry G, Nunomura A, Hirai K, Zhu X, Perez M, Avila J, Castellani RJ, Atwood CS, Aliev G, Sayre LM, Takeda A, Smith MA (2002) Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic Biol Med 33(11):1475-1479
4. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in alzheimer's. Nature 382(6587):120-121
5. Boyd-Kimball D, Castegna A, Sultana R (2005) Fai Poon H, Petroze R, Lynn BC, Klein JB, Butterfield DA. Proteomic identification of proteins oxidized by Abeta (1-42) in synaptosomes:implications for Alzheimer's disease. Brain Res 1044(2):206-215
6. Liu Q, Raina AK, Smith MA, Sayre LM, Perry G (2003) Hydroxynonenal, toxic carbonyls, and Alzheimer disease. Mole Aspects Med 24(4-5):305-313
7. Sultana R, Butterfield DA (2010) Role of oxidative stress in the progression of Alzheimer's disease. J Alzheimer Dis 19(1):341-353
8. Butterfield DA (2010) Bader Lange ML, Sultana R. Involvements of the Lipid Peroxidation Product, HNE, in the Pathogenesis and Progression of Alzheimer's Disease. Biochim Biophys Acta 1801(8):924-929
9. Butterfield DA, Drake J, Pocernich C, Castegna A (2001) Evidence of oxidative damage in Alzheimer's disease brain:Central role for amyloid beta-peptide. Trends Mol Med 7(12):548-554
10. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ 2nd (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87(23):9383-9387
11. Morrow JD (2000) The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab Rev 32(3-4):377-385
12. Lawson JA, Rokach J, FitzGerald GA (1999) Isoprostanes: formation, analysis and use as indices of lipid peroxidation. J Biol Chem 274(35):24441-24444
13. Zhang B, Tian M, Zhen Y, Yue Y, Sherman J, Zheng H, Li S, Tanzi RE, Marcantonio ER, Xie Z (2012) The effects of isoflurane and desflurane on cognitive function in humans. Anesth Analg 114(2):410-415
14. Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, Rabbitt P, Jolles J, Larsen K, Hanning CD, Langeron O, Johnson T, Lauven PM, Kristensen PA, Biedler A, van Beem H, Fraidakis O, Silverstein JH, Beneken JE, Gravenstein JS (1998) Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD Investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 351(9106):857-861
15. Steinmetz J, Christensen KB, Lund T, Lohse N (2009) ISPOCD Group. Long-term consequences of postoperative cognitive dysfunction. Anesthesiology 110(3):548-555
16. Jackson S (1966) Creatinine in urine as an index of urinary excretion rate. Health Phys 12(6):843-850
17. Khalil AM, Gagaa M, Alshamali A (2012) 8-Oxo-7,8-dihydro-2′- deoxyguanosine as a biomarker of DNA damage by mobile phone radiation. Hum Exp Toxicol 31(7):734-740
18. Tsai JP, Liou JH, Yeh KT, Tai HC, Cheng YW, Chang HR (2011) Intensity of cytosol expression of 8-OHdG in normal renal tubules is associated with the severity of renal fibrosis. Swiss Med Wkly 141:w13268
19. Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11(1):81-128
20. Montine TJ, Morrow JD (2005) Fatty acid oxidation in the pathogenesis of Alzheimer's disease. Am J Pathol 166(5):1283-1289
21. Shi GX, Liu CZ, Wang LP, Guan LP, Li SQ (2012) Biomarkers of Oxidative Stress in Vascular Dementia Patients. Can J Neurol Sci 39(1):65-68
22. Yao Y, Zhukareva V, Sung S, Clark CM, Rokach J, Lee VM, Trojanowski JQ, Pratico D (2003) Enhanced brain levels of 8,12-iso-iPF2alpha-VI differentiate AD from frontotemporal dementia. Neurology 61(4):475-478
23. Ansari MA, Scheff SW (2010) Oxidative stress in the progression of alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69(2):155-167
24. Torres LL, Quaglio NB, de Souza GT, Garcia RT, Dati LM, Moreira WL, Loureiro AP, de Souza-Talarico JN, Smid J, Porto CS, Bottino CM, Nitrini R, Barros SB, Camarini R (2011) Alzheimers dis. peripheral oxidative stress biomarkers in mild cognitive impairment and alzheimer's disease. J Alzheimers Dis. 26(1):59-68
25. Drury JA, Nycyk JA, Cooke RW (1997) Comparison of urinary and plasma malondialdehyde in preterm infants. Clin Chim Acta 263(2):177-185
26. McGrath LT, McGleenon BM, Brennan S, McColl D, McILroy S, Passmore AP (2001) Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM 94(9):485-490
27. Scholpp J, Schubert JK, Miekisch W, Noeldge-Schomburg GF (2004) Lipid peroxidation early after brain injury. J Neurotrauma 21(6):667-677
28. Cernak I, Savic VJ, Kotur J, Prokic V, Veljovic M, Grbovic D (2000) Characterization of plasma magnesium concentration and oxidative stress following graded traumatic brain injury in humans. J Neurotrauma 17(1):53-68